Roche Holding AG's acquisition of 89bio, Inc. to expand cardiometabolic offerings and drive growth beyond GLP-1. Click for ...

And indeed, in some areas, particularly in oncology, there is scientific progress being made in precision medicine. But in ...

The number of people living with dementia worldwide is projected to reach around 153 million by 2050, while in Australia, it is estimated more than 433,000 people are currently living with dementia, ...

The first new Alzheimer’s drug approved for use in Australia in 25 years, ticked off by the Therapeutic Goods Association in ...

Already, God is weaving goodness and beauty from the tangle of Satan’s poisonous strands. Kirk’s message is reaching tens of ...

Australia is engaged in what has now become a global debate over how to diagnose and deliver care for people with Alzheimer’s disease, the most common cause of dementia.

GLP-1RA use, compared with basal insulin and DPP-4i use, was associated with lower risks for IBD and hospitalization in type 2 diabetes.

Should you apply to grad school? From setting yourself up for success during undergrad to knowing what to expect — this is your guide.

At the ET Soonicorns Summit 2025, leaders from healthtech, agritech, fintech, edtech, and frontier tech gathered in a closed-door roundtable to blueprint India’s next economy. From AI diagnostics and ...

Over the past decade, the landscape of cancer research has undergone a remarkable transformation. Driven by rapid advancements in high-throughput omics ...